RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. LoQus23

LoQus23

We are developing small molecule somatic expansion inhibitors for the treatment of Huntington’s Disease and other triplet repeat expansion diseases.

Latest funding

Series A ·

Amount not disclosed in a source on record.

All 2 rounds ↓
Website: loqus23.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Genetics, Health Care, Medical.
Stage: Series A.
Based in: Cambridge, United Kingdom.
Last round: Oct 2, 2024 · 775 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMar 26, 2019 (7 years old)

Funding rounds

DateRoundAmountLeadSource
Series Aundisclosed—fundraisingfox.com
Seedundisclosed—fundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like LoQus23

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/loqus23 (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy